Financials Livingstone Health Holdings Limited
Equities
PRH
SGXE70643320
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 SGD | -6.25% | -6.25% | -50.00% |
02-12 | Livingstone Health to Sell Over 55.5 Million Shares | MT |
2023 | Livingstone Health Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
Valuation
Fiscal Period: March | 2021 | 2022 | 2023 |
---|---|---|---|
Capitalization 1 | 59.08 | 46.24 | 22.26 |
Enterprise Value (EV) 1 | 61.21 | 47.79 | 25.94 |
P/E ratio | -4.42 x | 15.3 x | 30.8 x |
Yield | - | 0.83% | - |
Capitalization / Revenue | 3.04 x | 1.35 x | 0.68 x |
EV / Revenue | 3.15 x | 1.4 x | 0.79 x |
EV / EBITDA | 14.4 x | 8.67 x | 7.36 x |
EV / FCF | - | 235 x | 10.5 x |
FCF Yield | - | 0.43% | 9.53% |
Price to Book | 39.1 x | 9.26 x | 4.28 x |
Nbr of stocks (in thousands) | 315,948 | 318,891 | 436,391 |
Reference price 2 | 0.1870 | 0.1450 | 0.0510 |
Announcement Date | 7/15/21 | 7/12/22 | 7/12/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales 1 | 8.903 | 6.159 | 19.42 | 34.14 | 32.92 |
EBITDA 1 | 3.881 | 1.209 | 4.25 | 5.515 | 3.524 |
EBIT 1 | 3.659 | 0.7199 | 3.094 | 3.972 | 1.598 |
Operating Margin | 41.09% | 11.69% | 15.93% | 11.63% | 4.85% |
Earnings before Tax (EBT) 1 | 3.662 | 0.4905 | -12.96 | 4.249 | 1.797 |
Net income 1 | 3.204 | 1.83 | -13.35 | 3.025 | 0.7227 |
Net margin | 35.98% | 29.72% | -68.76% | 8.86% | 2.2% |
EPS 2 | 7.577 | 5.195 | -0.0423 | 0.009500 | 0.001656 |
Free Cash Flow 1 | 0.1435 | 3.11 | - | 0.2036 | 2.471 |
FCF margin | 1.61% | 50.49% | - | 0.6% | 7.51% |
FCF Conversion (EBITDA) | 3.7% | 257.22% | - | 3.69% | 70.13% |
FCF Conversion (Net income) | 4.48% | 169.9% | - | 6.73% | 341.9% |
Dividend per Share | - | - | - | 0.001200 | - |
Announcement Date | 6/28/19 | 12/31/20 | 7/15/21 | 7/12/22 | 7/12/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net Debt 1 | - | 0.15 | 2.13 | 1.55 | 3.68 |
Net Cash position 1 | 3.01 | - | - | - | - |
Leverage (Debt/EBITDA) | - | 0.1266 x | 0.5017 x | 0.2816 x | 1.045 x |
Free Cash Flow 1 | 0.14 | 3.11 | - | 0.2 | 2.47 |
ROE (net income / shareholders' equity) | 81.7% | 7.91% | - | 93.4% | 21.4% |
ROA (Net income/ Total Assets) | 34.6% | 4.56% | - | 12% | 4.55% |
Assets 1 | 9.26 | 40.16 | - | 25.2 | 15.88 |
Book Value Per Share | - | 11.60 | 0 | 0.0200 | 0.0100 |
Cash Flow per Share | - | 4.860 | 0.0200 | 0.0200 | 0.0100 |
Capex 1 | 0.27 | 0.74 | 0.24 | 0.98 | 0.98 |
Capex / Sales | 3.06% | 12.06% | 1.26% | 2.88% | 2.99% |
Announcement Date | 6/28/19 | 12/31/20 | 7/15/21 | 7/12/22 | 7/12/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-50.00% | 5.45M | |
-19.34% | 16.51B | |
+5.41% | 12.53B | |
+4.64% | 11.74B | |
+2.21% | 10.06B | |
+29.17% | 8.71B | |
-3.46% | 7.57B | |
+18.60% | 7.14B | |
+4.93% | 6.68B | |
+44.78% | 4.54B |
- Stock Market
- Equities
- PRH Stock
- Financials Livingstone Health Holdings Limited